Key facts
- Robert F. Kennedy Jr. is campaigning across the U.S. to promote his health agenda and support Republican candidates.
- Kennedy's 'Take Back Your Health' campaign has visited 19 states since January.
- Supporters of Kennedy's Make America Healthy Again (MAHA) movement are frustrated by perceived policy constraints and appointments within the Health Department.
- Recent appointments to lead the CDC and FDA have faced criticism from MAHA advocates.
- The White House maintains its commitment to the MAHA agenda, highlighting policy initiatives and executive orders.
Robert F. Kennedy Jr. is actively touring the country, engaging with Republican candidates and promoting his health agenda, a strategy the White House hopes will boost GOP turnout in upcoming elections. His "Take Back Your Health" campaign has already visited 19 states since January, with recent stops in Iowa, Nebraska, and Minnesota.
However, the campaign trail activities are met with internal friction. Supporters of Kennedy's Make America Healthy Again (MAHA) movement express concern that while Kennedy is "unleashed" to discuss his popular issues, his policy agenda in Washington faces constraints. They cite recent appointments to lead the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) as departures from the movement's core values, particularly regarding vaccine mandates and pesticide use.
Leaders within the MAHA movement, such as Alex Clark, have voiced frustration, questioning why their battles are not being fought more aggressively within the administration. This sentiment is amplified by policy decisions, like an executive order protecting glyphosate production, which they view as concessions to industry interests that contradict Kennedy's stated goals.
The White House, through spokesperson Kush Desai, defends its commitment to the MAHA agenda, calling it a "pledge to tackle America’s chronic disease epidemic" and highlighting policy rollouts and executive orders as evidence of progress. Desai also defended the nominated officials, including Heidi Overton for FDA commissioner and Erica Schwartz for CDC director, as "MAHA warriors" who have championed the administration's health initiatives.
Despite these assurances, some MAHA activists remain unconvinced, feeling that key leadership positions are being filled by individuals who do not share Kennedy's values, potentially undermining the movement's influence within the administration.